bpc-157 compounding restrictions fda Advisers Vote to Ease on BPC-157, TB-500, and Other Novel Peptides — Glitchwire NBC News | The claims

Ever feel like you're on a never-ending treadmill of fatigue, brain fog, and unexplained mood swings

Peptide may be degraded

It is typically mild to moderate, dose-dependent, and tends to resolve within the first few weeks at each dose level during titration

This delivers the highest local concentration but can be difficult to perform on yourself

As you age, NAD+ levels decline and leading to decreased cellular function and increased inflammation

So we're still in this model of being hyperfocused on the trigger whether it's an infectious trigger or whatever else and we're not looking at, physiologically, what has created this undermining of the immune system